Shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares trading hands.
H. Lundbeck A/S Trading Down 0.0 %
The firm’s 50 day moving average is $22.00 and its 200 day moving average is $22.00. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The company has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
See Also
- Five stocks we like better than H. Lundbeck A/S
- Technology Stocks Explained: Here’s What to Know About Tech
- 3 Must-Have ETFs Set to Dominate This Quarter
- Buy P&G Now, Before It Sets A New All-Time High
- Seeking Stability? These 3 Stocks Offer Strong Potential
- 3 Small Caps With Big Return Potential
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
